Melguizo Alonso, Consolación Author
Characterization of a new human embryonal rhabdomyosarcoma cell line, RMS-GR
- Fernandez, JE
- Prados, J
- Melguizo, C
- Arena, N
- Malavasi, F
- Alvarez, L
- Aranega, A
Japanese Journal of Cancer Research - 1/05/1998
10.1111/j.1349-7006.1998.tb03293.x
- JCR Quartile: Q2 (1998)
- JCR Impact Factor: 1.984 (2022)
- Category normalized Impact: 0.105 (1998)
- Scopus
- ORCID
- Web of Science
Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
- Carrillo, E
- Marchal, JA
- Prados, J
- Melguizo, C
- Velez, C
- Arena, N
- Alvarez, L
- Serrano, S
- Aranega, A
Cellular and molecular biology (Noisy-le-Grand, France) - 1/12/1998
- JCR Quartile: Q3 (1998)
- JCR Impact Factor: 1.151 (2022)
- Category normalized Impact: 0.11 (1998)
- CiteScore: 2.5 (2020)
- Scopus
- ORCID
- Web of Science
GR-891: A novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells
- Marchal, JA
- Prados, J
- Melguizo, C
- Gomez, JA
- Campos, J
- Gallo, MA
- Espinosa, A
- Arena, N
- Aranega, A
British Journal of Cancer - 23/02/1999
- JCR Quartile: Q1 (1999)
- SJR Quartile: Q1
- JCR Impact Factor: 3.282 (2022)
- Category normalized Impact: 0.309 (1999)
- CiteScore: 10.7 (2020)
- SJR: 1.242 (1999
- SNIP: 1.269 (1999
- SJR Categories: Cancer Research (Q1); Oncology (Q1)
- Scopus
- ORCID
- Web of Science
Multidrug resistance phenotype in the RMS-GR human rhabdomyosarcoma cell line obtained after polychemotherapy
- Prados, J
- Melguizo, C
- Marchal, JA
- Velez, C
- Alvarez, L
- Aranega, A
Japanese Journal of Cancer Research - 1/07/1999
10.1111/j.1349-7006.1999.tb00816.x
- JCR Quartile: Q2 (1999)
- JCR Impact Factor: 2.117 (2022)
- Category normalized Impact: 0.019 (1999)
- Scopus
- ORCID
- Web of Science
Modulation of α-actin and α-actinin proteins in cardiomyocytes by retinoic acid during development
- Aranega, AE
- Velez, C
- Prados, J
- Melguizo, C
- Marchal, JA
- Arena, N
- Alvarez, L
- Aranega, A
Cells Tissues Organs - 17/7/1999
- JCR Quartile: Q4 (1999)
- SJR Quartile: Q2
- JCR Impact Factor: 2.064 (2022)
- Category normalized Impact: 0.249 (1999)
- CiteScore: 4.1 (2020)
- SJR: 0.486 (1999
- SNIP: 0.479 (1999
- SJR Categories: Anatomy (Q2); Histology (Q2)
- Scopus
- ORCID
- Web of Science
Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602)
- Marchal, JA
- Melguizo, C
- Prados, J
- Aranega, AE
- Gomez, JA
- Campos, J
- Gallo, MA
- Espinosa, A
- Arena, N
- Aranega, A
Japanese Journal of Cancer Research - 1/09/2000
10.1111/j.1349-7006.2000.tb01037.x
- JCR Quartile: Q2 (2000)
- JCR Impact Factor: 2.12 (2022)
- Category normalized Impact: 0.197 (2000)
- Scopus
- ORCID
- Web of Science
Development of chick cardiomyocytes: Modulation of intermediate filaments by basic fibroblast and platelet-derived growth factors
- Velez, C
- Aranega, AE
- Marchal, JA
- Melguizo, C
- Prados, JC
- Carrillo, E
- Aranega, A
Cells Tissues Organs - 1/1/2000
- JCR Quartile: Q3 (2000)
- SJR Quartile: Q2
- JCR Impact Factor: 0.896 (2022)
- Category normalized Impact: 0.125 (2000)
- CiteScore: 4.1 (2020)
- SJR: 0.427 (2000
- SNIP: 0.602 (2000
- SJR Categories: Anatomy (Q2); Histology (Q3)
- Scopus
- ORCID
- Web of Science
Reverse transcriptase-polymerase chain reaction detection of circulating tumor cells in patients with melanoma: Correlation with clinical stage, tumor thickness and histological type
- Carrillo, E
- Prados, J
- Melguizo, C
- Marchal, JA
- Velez, C
- Serrano, S
- Boulaiz, H
- Merida, JA
- Aranega, A
Pathology International - 13/04/2002
10.1046/j.1440-1827.2002.01344.x
- JCR Quartile: Q3 (2002)
- SJR Quartile: Q1
- JCR Impact Factor: 0.935 (2022)
- Category normalized Impact: 0.231 (2002)
- CiteScore: 3 (2020)
- SJR: 0.461 (2002
- SNIP: 0.699 (2002
- SJR Categories: Medicine (miscellaneous) (Q1); Pathology and Forensic Medicine (Q2)
- Scopus
- ORCID
- Web of Science
Transfection of MS-36 melanoma cells with gef gene inhibits proliferation and induces modulation of the cell cycle
- Boulaiz, H
- Prados, J
- Marchal, JA
- Garcia, AM
- Alvarez, L
- Melguizo, C
- Carrillo, E
- Ramos, JL
- Aranega, A
Cancer Science - 1/06/2003
10.1111/j.1349-7006.2003.tb01483.x
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 4.966 (2022)
- Category normalized Impact: 0.22 (2003)
- CiteScore: 8.5 (2020)
- SJR: 0.773 (2003
- SNIP: 0.671 (2003
- SJR Categories: Medicine (miscellaneous) (Q1); Cancer Research (Q2); Oncology (Q2)
- Scopus
- ORCID
- Web of Science
Inhibition of growth and induction of apoptosis in human breast cancer by transfection of gef gene
- Boulaiz, H
- Prados, J
- Melguizo, C
- Garcia, AM
- Marchal, JA
- Ramos, JL
- Carrillo, E
- Velez, C
- Aranega, A
British Journal of Cancer - 7/07/2003
- JCR Quartile: Q1 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 3.894 (2022)
- Category normalized Impact: 0.49 (2003)
- CiteScore: 10.7 (2020)
- SJR: 1.662 (2003
- SNIP: 1.37 (2003
- SJR Categories: Cancer Research (Q1); Oncology (Q1)
- Scopus
- ORCID
- Web of Science
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
This author has no conferences.
This author has no patents.
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- JCR Impact Factor: 4.9 (2023)
- JCR 5-year Impact Factor: 5.5
- JCR Categories: PHARMACOLOGY & PHARMACY
- Scopus
- ORCID
- Web of Science
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador